SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-011580
Filing Date
2019-02-28
Accepted
2019-02-28 16:45:47
Documents
5
Period of Report
2019-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-5056_18k.htm 8-K 25312
2 EX-99.1 a19-5056_1ex99d1.htm EX-99.1 81159
3 EX-99.2 a19-5056_1ex99d2.htm EX-99.2 20859
4 GRAPHIC g50561moi001.jpg GRAPHIC 3171
5 GRAPHIC g50561mmi001.jpg GRAPHIC 3171
  Complete submission text file 0001104659-19-011580.txt   137599
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 19644125
SIC: 2834 Pharmaceutical Preparations